Sign in or create an account to add this stock to your watchlist.
About Innospec (NASDAQ:IOSP)
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and mining markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in an environmental remediation business that manages the cleanup of redundant TEL plants. The company serves oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, formulators of personal care and home care, agrochemical and mining formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Industry, Sector and Symbol
Industry Chemicals & allied products
Trailing P/E Ratio16.26
Forward P/E Ratio17.22
Sales & Book Value
Annual Sales$1.31 billion
Price / Sales1.41
Cash Flow$6.8243 per share
Price / Cash11.10
Book Value$33.80 per share
Price / Book2.24
EPS (Most Recent Fiscal Year)$4.66
Net Income$61.80 million
Return on Equity14.91%
Return on Assets8.37%
Innospec (NASDAQ:IOSP) Frequently Asked Questions
What is Innospec's stock symbol?
Innospec trades on the NASDAQ under the ticker symbol "IOSP."
How often does Innospec pay dividends? What is the dividend yield for Innospec?
Innospec announced a semiannual dividend on Wednesday, May 9th. Stockholders of record on Monday, May 21st will be given a dividend of $0.44 per share on Thursday, May 31st. This represents a dividend yield of 1.18%. The ex-dividend date is Friday, May 18th. This is a positive change from Innospec's previous semiannual dividend of $0.39. View Innospec's Dividend History.
How were Innospec's earnings last quarter?
Innospec (NASDAQ:IOSP) released its quarterly earnings results on Tuesday, May, 8th. The specialty chemicals company reported $1.02 EPS for the quarter, beating the consensus estimate of $0.91 by $0.11. The specialty chemicals company had revenue of $360.70 million for the quarter, compared to analyst estimates of $308.90 million. Innospec had a return on equity of 14.91% and a net margin of 4.86%. Innospec's revenue was up 22.6% on a year-over-year basis. During the same quarter last year, the business earned $1.00 earnings per share. View Innospec's Earnings History.
When is Innospec's next earnings date?
What price target have analysts set for IOSP?
3 brokers have issued twelve-month target prices for Innospec's stock. Their predictions range from $65.00 to $65.00. On average, they anticipate Innospec's stock price to reach $65.00 in the next year. View Analyst Ratings for Innospec.
Who are some of Innospec's key competitors?
Some companies that are related to Innospec include Olin (OLN), W. R. Grace and (GRA), Ashland (ASH), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), KMG Chemicals (KMG), Innophos (IPHS), OCI Partners (OCIP), Nexeo Solutions (NXEO), Hawkins (HWKN), Liquidmetal Technologies (LQMT) and Gulf Resources (GURE).
Who are Innospec's key executives?
Innospec's management team includes the folowing people:
- Mr. Patrick S. Williams, Pres, CEO & Director (Age 53)
- Mr. Ian P. Cleminson, Exec. VP & CFO (Age 52)
- Dr. Philip J. Boon, COO & Exec. VP (Age 59)
- Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 69)
- Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 59)
Has Innospec been receiving favorable news coverage?
Media stories about IOSP stock have been trending positive recently, according to Accern Sentiment. The research group identifies negative and positive news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Innospec earned a coverage optimism score of 0.33 on Accern's scale. They also assigned media coverage about the specialty chemicals company an impact score of 48.99 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
Who are Innospec's major shareholders?
Innospec's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.03%), Dimensional Fund Advisors LP (6.01%), Wells Fargo & Company MN (4.58%), Champlain Investment Partners LLC (3.39%), Northern Trust Corp (2.01%) and Westwood Holdings Group Inc. (1.63%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Joachim Roeser, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.
Which institutional investors are selling Innospec stock?
IOSP stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Millennium Management LLC, American Century Companies Inc., Thrivent Financial for Lutherans, Opus Capital Group LLC, Virginia Retirement Systems ET AL, First Wilshire Securities Management Inc. and BNP Paribas Arbitrage SA. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, David Earl Williams, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.
Which institutional investors are buying Innospec stock?
IOSP stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Dean Investment Associates LLC, Dimensional Fund Advisors LP, Wells Fargo & Company MN, Champlain Investment Partners LLC, WBI Investments Inc., Westwood Holdings Group Inc. and Hsbc Holdings PLC. View Insider Buying and Selling for Innospec.
How do I buy shares of Innospec?
Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Innospec's stock price today?
One share of IOSP stock can currently be purchased for approximately $75.75.
How big of a company is Innospec?
Innospec has a market capitalization of $1.85 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.
How can I contact Innospec?
Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]
MarketBeat Community Rating for Innospec (IOSP)MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
Innospec (NASDAQ:IOSP) Price Target and Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Innospec in the last 12 months. Their average twelve-month price target is $65.00, suggesting that the stock has a possible downside of 14.19%. The high price target for IOSP is $65.00 and the low price target for IOSP is $65.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Hold||Hold||Hold|
|Consensus Rating Score: ||2.67||2.33||2.33||2.33|
|Ratings Breakdown: ||0 Sell Rating(s)|
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$65.00||$65.00||$65.00||$65.00|
|Price Target Upside: ||14.19% downside||3.35% downside||3.35% downside||3.35% downside|
Innospec (NASDAQ:IOSP) Consensus Price Target History
Innospec (NASDAQ:IOSP) Analyst Ratings History
(Data available from 5/20/2016 forward)
Innospec (NASDAQ:IOSP) Dividend Information
Innospec pays an annual dividend of $0.78 per share, with a dividend yield of 1.03%. IOSP's next semiannual dividend payment will be made on Thursday, May 31. Innospec pays out 16.74% of its earnings out as a dividend.
|Payout Ratio(s):||16.74% (Trailing 12 Months of Earnings) |
17.73% (Based on This Year's Estimates)
16.77% (Based on Next Year's Estimates)
11.43% (Based on Cash Flow)
Innospec (NASDAQ:IOSP) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Innospec (NASDAQ IOSP) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.02%
Institutional Ownership Percentage: 89.35%
Innospec (NASDAQ IOSP) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|5/14/2018||Philip Curran||Insider||Sell||2,000||$73.63||$147,260.00||4,218|| |
|3/15/2018||Philip John Boon||VP||Sell||3,558||$69.69||$247,957.02||31,000|| |
|3/7/2018||Philip Curran||Insider||Sell||1,268||$68.24||$86,528.32||2,998|| |
|2/26/2018||Catherine Hessner||VP||Sell||1,382||$68.24||$94,307.68||27,518|| |
|2/23/2018||David Earl Williams||Insider||Sell||3,142||$68.54||$215,352.68||16,676|| |
|2/23/2018||Ian Cleminson||CFO||Sell||2,261||$68.55||$154,991.55||26,685|| |
|2/21/2018||Philip John Boon||VP||Sell||501||$67.04||$33,587.04||35,439|| |
|11/30/2017||Ian Cleminson||CFO||Sell||5,000||$71.67||$358,350.00||22,997|| |
|11/29/2017||Milton C Blackmore||Director||Sell||977||$73.67||$71,975.59||6,977|| |
|11/28/2017||Catherine Hessner||VP||Sell||707||$71.56||$50,592.92||25,791|| |
|11/28/2017||Ian Cleminson||CFO||Sell||515||$71.56||$36,853.40||28,878|| |
|11/28/2017||Philip Curran||Insider||Sell||375||$71.56||$26,835.00||2,968|| |
|11/24/2017||Philip Curran||Insider||Sell||1,352||$71.05||$96,059.60|| |
|11/22/2017||Patrick Williams||CEO||Sell||15,000||$71.49||$1,072,350.00||174,242|| |
|11/21/2017||Brian Watt||VP||Sell||440||$70.17||$30,874.80||30,730|| |
|9/7/2017||Milton C Blackmore||Director||Buy||442||$54.75||$24,199.50||6,000|| |
|3/17/2017||Patrick Williams||CEO||Sell||3,000||$63.01||$189,030.00||200,265|| |
|2/17/2017||Catherine Hessner||VP||Sell||3,664||$70.91||$259,814.24||30,705|| |
|2/17/2017||Ian Cleminson||CFO||Sell||5,157||$70.91||$365,682.87||31,470|| |
|12/6/2016||Milton C Blackmore||Director||Sell||1,089||$68.35||$74,433.15||6,647|| |
|11/22/2016||Ian Malcolm Mcrobbie||VP||Sell||20,614||$66.27||$1,366,089.78||42,543|| |
|11/18/2016||Hugh Aldous||Director||Sell||672||$63.15||$42,436.80||15,060|| |
|11/16/2016||Brian Watt||VP||Sell||3,000||$61.30||$183,900.00||32,089|| |
|11/14/2016||Joachim Roeser||Director||Sell||8,333||$60.53||$504,396.49||8,120|| |
|11/11/2016||Patrick Williams||CEO||Sell||17,342||$60.04||$1,041,213.68||196,926|| |
|3/16/2016||Patrick Joseph Mcduff||EVP||Sell||489||$43.05||$21,051.45|| |
|3/2/2016||Catherine Hessner||VP||Sell||1,455||$43.80||$63,729.00||30,983|| |
|2/29/2016||Patrick Joseph Mcduff||EVP||Sell||5,540||$43.56||$241,322.40||1,966|| |
|2/23/2016||Ian Cleminson||CFO||Sell||1,527||$43.72||$66,760.44||28,116|| |
|2/23/2016||Patrick Williams||CEO||Sell||2,066||$43.72||$90,325.52||207,217|| |
|12/4/2015||Martin Demora Hale||Director||Sell||10,000||$57.13||$571,300.00||181,480|| |
|11/30/2015||Patrick Williams||CEO||Sell||12,800||$58.42||$747,776.00||187,242|| |
|11/23/2015||Brian Watt||VP||Sell||3,000||$57.47||$172,410.00||34,644|| |
|11/18/2015||Ian Malcolm Mcrobbie||VP||Sell||10,156||$57.30||$581,938.80||40,889|| |
|11/18/2015||Patrick Joseph Mcduff||EVP||Sell||8,025||$57.50||$461,437.50|| |
|6/2/2015||Philip John Boon||VP||Sell||13,000||$43.04||$559,520.00|| |
|5/11/2015||Catherine Hessner||VP||Sell||5,000||$44.03||$220,150.00|| |
|3/10/2015||David Earl Williams||Insider||Sell||5,060||$43.14||$218,288.40|| |
|3/4/2015||Brian Watt||VP||Sell||3,000||$44.14||$132,420.00|| |
|3/2/2015||Patrick Williams||CEO||Sell||7,338||$45.12||$331,090.56|| |
|2/24/2015||Ian Cleminson||CFO||Sell||5,092||$43.90||$223,538.80|| |
|2/24/2015||Ian Malcolm Mcrobbie||VP||Sell||3,060||$43.90||$134,334.00|| |
|2/24/2015||Philip Curran||Insider||Sell||1,375||$43.90||$60,362.50|| |
|12/1/2014||Hugh Aldous||Director||Buy||1,000||$42.96||$42,960.00|| |
|8/15/2014||Hugh Aldous||Director||Buy||1,590||$40.41||$64,251.90|| |
|2/25/2014||Patrick Williams||CEO||Sell||4,800||$43.67||$209,616.00|| |
|2/18/2014||Ian Cleminson||CFO||Sell||4,819||$44.26||$213,288.94|| |
|11/20/2013||Ian Malcolm Mcrobbie||VP||Sell||15,000||$45.11||$676,650.00|| |
|8/29/2013||Philip John Boon||VP||Sell||1,923||$41.22||$79,266.06|| |
|5/22/2013||Mark Bracewell||Insider||Sell||1,060||$41.02||$43,481.20|| |
|5/9/2013||Catherine Hessner||VP||Sell||5,277||$40.69||$214,721.13|| |
|5/9/2013||Mark Bracewell||Insider||Sell||4,051||$40.69||$164,835.19|| |
|3/6/2013||Ian Malcolm Mcrobbie||VP||Sell||2,886||$41.69||$120,317.34|| |
|2/15/2013||Mark Bracewell||Insider||Sell||1,260||$41.19||$51,899.40|| |
Innospec (NASDAQ IOSP) News Headlines
|Innospec (IOSP) Upgraded at Zacks Investment Research|
www.americanbankingnews.com - May 19 at 12:52 AM
|KeyCorp Comments on Innospec's Q2 2018 Earnings (IOSP)|
www.americanbankingnews.com - May 18 at 7:30 AM
|Q4 2018 Earnings Estimate for Innospec (IOSP) Issued By KeyCorp|
www.americanbankingnews.com - May 17 at 8:21 AM
|Philip Curran Sells 2,000 Shares of Innospec (IOSP) Stock|
www.americanbankingnews.com - May 15 at 4:18 PM
|Should You Be Tempted To Sell Innospec Inc (NASDAQ:IOSP) At Its Current PE Ratio?|
finance.yahoo.com - May 14 at 4:30 PM
| Brokerages Expect Innospec (IOSP) Will Announce Earnings of $1.08 Per Share|
www.americanbankingnews.com - May 12 at 9:20 PM
|Innospec Has The Opportunity To Leverage Self-Help And Growth Markets|
seekingalpha.com - May 11 at 4:30 PM
|BRIEF-Innospec Reports Q1 Earnings Per Share $0.90|
www.reuters.com - May 10 at 4:37 PM
www.streetinsider.com - May 10 at 4:37 PM
|Edited Transcript of IOSP earnings conference call or presentation 9-May-18 1:00pm GMT|
finance.yahoo.com - May 10 at 9:41 AM
|Innospec (IOSP) to Issue Semiannual Dividend of $0.44|
www.americanbankingnews.com - May 9 at 5:41 PM
|Innospec's (IOSP) CEO Patrick Williams on Q1 2018 Results - Earnings Call Transcript|
seekingalpha.com - May 9 at 4:31 PM
|Innospec Reports First Quarter 2018 Financial Results|
globenewswire.com - May 9 at 9:30 AM
|Innospec: 1Q Earnings Snapshot|
finance.yahoo.com - May 9 at 9:30 AM
|Innospec (IOSP) Posts Earnings Results, Beats Estimates By $0.10 EPS|
www.americanbankingnews.com - May 8 at 7:50 PM
|Innospec (IOSP) Given Average Rating of "Buy" by Analysts|
www.americanbankingnews.com - May 8 at 1:32 AM
|FMC (FMC) & Innospec (IOSP) Critical Analysis|
www.americanbankingnews.com - May 5 at 10:13 AM
|Innospec (IOSP) Lowered to Buy at ValuEngine|
www.americanbankingnews.com - May 4 at 12:24 AM
|Hawkins (HWKN) & Innospec (IOSP) Head-To-Head Analysis|
www.americanbankingnews.com - May 3 at 11:17 AM
|Innospec (IOSP) Set to Announce Quarterly Earnings on Tuesday|
www.americanbankingnews.com - May 1 at 2:08 AM
|Critical Review: The Chemours (CC) and Innospec (IOSP)|
www.americanbankingnews.com - April 30 at 1:21 PM
| Brokerages Anticipate Innospec (IOSP) to Announce $0.98 EPS|
www.americanbankingnews.com - April 25 at 9:54 AM
|Innospec (IOSP) Stock Rating Upgraded by ValuEngine|
www.americanbankingnews.com - April 25 at 12:58 AM
|Innospec (IOSP) Lifted to Buy at Johnson Rice|
www.americanbankingnews.com - April 24 at 9:28 AM
|Innospec (IOSP) Upgraded to Buy by BidaskClub|
www.americanbankingnews.com - April 19 at 9:58 AM
|Innospec (IOSP) Upgraded to Hold by Zacks Investment Research|
www.americanbankingnews.com - April 19 at 6:36 AM
|Zacks Investment Research Downgrades Innospec (IOSP) to Hold|
www.americanbankingnews.com - April 18 at 10:16 PM
|Innospec (IOSP) Lowered to "Strong Sell" at BidaskClub|
www.americanbankingnews.com - April 15 at 1:17 PM
|Innospec (IOSP) Receives Average Rating of "Hold" from Analysts|
www.americanbankingnews.com - April 13 at 1:41 AM
|Global Oxygen Scavengers Market Opportunities 2018: Clariant International AG., Innospec , Accepta AS, BASF SE, Baker Hughes Incorporated|
www.marketwatch.com - April 10 at 9:52 AM
|Innospec Schedules First Quarter 2018 Earnings Release and Conference Call|
finance.yahoo.com - April 10 at 9:52 AM
|Innospec (IOSP) Downgraded to Hold at Zacks Investment Research|
www.americanbankingnews.com - April 9 at 8:12 AM
| Analysts Anticipate Innospec (IOSP) Will Post Earnings of $0.98 Per Share|
www.americanbankingnews.com - April 8 at 11:19 AM
|Innospec (IOSP) Rating Lowered to Hold at Zacks Investment Research|
www.americanbankingnews.com - April 6 at 8:10 PM
|Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results|
finance.yahoo.com - April 5 at 9:00 AM
|Innospec (IOSP) Upgraded by ValuEngine to Buy|
www.americanbankingnews.com - April 1 at 12:08 AM
|Monness Crespi & Hardt Lowers Innospec (IOSP) to Neutral|
www.americanbankingnews.com - March 31 at 7:42 PM
|Innospec (IOSP) Downgraded by Zacks Investment Research to Hold|
www.americanbankingnews.com - March 29 at 7:58 PM
|SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Innospec Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors|
finance.yahoo.com - March 26 at 9:54 AM
|Form DEFA14A INNOSPEC INC.|
www.streetinsider.com - March 23 at 9:27 AM
|Zacks: Brokerages Anticipate Innospec Inc. (IOSP) to Post $0.98 EPS|
www.americanbankingnews.com - March 22 at 11:26 AM
|BRIEF-Innospec Says CEO Patrick Williams' FY 2017 Total Compensation Was $7.4 Mln Vs $6.8 Mln|
www.reuters.com - March 22 at 9:43 AM
|Innospec Inc. (IOSP) Receives Consensus Rating of "Hold" from Analysts|
www.americanbankingnews.com - March 19 at 1:34 AM
|Innospec Inc. (IOSP) VP Philip John Boon Sells 3,558 Shares|
www.americanbankingnews.com - March 16 at 1:19 PM
|Innospec (IOSP) Raised to Hold at BidaskClub|
www.americanbankingnews.com - March 11 at 12:16 AM
|Innospec Inc. (IOSP) Insider Philip Curran Sells 1,268 Shares|
www.americanbankingnews.com - March 9 at 1:03 PM
|Innospec Inc. (IOSP) Shares Sold by Huber Capital Management LLC|
www.americanbankingnews.com - March 6 at 9:50 AM
|$0.98 EPS Expected for Innospec Inc. (IOSP) This Quarter|
www.americanbankingnews.com - March 5 at 9:38 AM
|Arizona State Retirement System Has $2.86 Million Position in Innospec Inc. (IOSP)|
www.americanbankingnews.com - March 5 at 4:40 AM
|Innospec (IOSP) versus KMG Chemicals (KMG) Critical Comparison|
www.americanbankingnews.com - March 4 at 5:10 AM
Innospec (NASDAQ:IOSP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Innospec (NASDAQ:IOSP) Income Statement, Balance Sheet and Cash Flow Statement
Innospec (NASDAQ IOSP) Stock Chart for Sunday, May, 20, 2018